9.04.20
8 min. Read

New Teladongo merger details. Pear’s acquisitive study strategy.

Issue 068

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote about Amwell's IPO filing and the possible longterm repercussions of Amazon's move into voice biomarkers via its first wearable device, Halo. Here's what's happening this week:

  • Teladoc-Livongo revealed more information about their multi-billion dollar merger in a lengthy government

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Quest bought Pack Health for $123M cash. Trials
4.21.23
6 min. Read
New digital health CPT code hopefuls. Trials
4.14.23
5 min. Read
Breaking: Pear Therapeutics files for Chapter 11 bankruptcy
4.07.23
4 min. Read
Pricing Database update: 60+ digital health prices.
4.05.23
3 min. Read
E&O readers analyze fate of Pear, PDTs. FDA-AI
3.31.23
8 min. Read
Seven secret health tech funding deals
3.27.23
3 min. Read
FDA waiver ends Nov 7. Withings ScanWatch recall, revs
3.24.23
10 min. Read
Pear seeks buyer. Lobbying for a CMS benefit category.
3.17.23
6 min. Read
CMS to pay for VR-based CBT. No HCPCS for CanvasDx.
3.10.23
8 min. Read
Omada Health’s all-time participant numbers. IBM employee benefits.
3.08.23
6 min. Read
  • First
  • Previous
  • 1 of 31
  • Next
  • Last